106 related articles for article (PubMed ID: 31941241)
1. [Abnormal expression of Wnt3a and inhibiting role of its molecular-targeted intervening in hepatocellular carcinoma].
Sai WL; Yao M; Zheng WJ; Wu MN; Sun JY; Pan LH; Dong ZZ; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):866-871. PubMed ID: 31941241
[No Abstract] [Full Text] [Related]
2. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF
World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑214 targets Wnt3a to suppress liver cancer cell proliferation.
Yang Y; Zhao Z; Hou N; Li Y; Wang X; Wu F; Sun R; Han J; Sun H; Song T; Huang C; Shao Y
Mol Med Rep; 2017 Nov; 16(5):6920-6927. PubMed ID: 28901526
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C
Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704
[TBL] [Abstract][Full Text] [Related]
6. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
7. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
8. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
9. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
[TBL] [Abstract][Full Text] [Related]
10. [Clinical values of Wnt3a as a novel biomarker in diagnosis and prognosis of hepatocellular carcinoma].
Wang L; Pan LH; Yao M; Zheng WJ; Fang M; Qiu LW; Dong ZZ; Yao DF
Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(44):3554-3558. PubMed ID: 27916074
[No Abstract] [Full Text] [Related]
11. GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit.
Li YH; Liu Y; Li YD; Liu YH; Li F; Ju Q; Xie PL; Li GC
World J Gastroenterol; 2012 Jun; 18(21):2704-11. PubMed ID: 22690081
[TBL] [Abstract][Full Text] [Related]
12. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
13. Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
Pan L; Yao M; Zheng W; Gu J; Yang X; Qiu L; Cai Y; Wu W; Yao D
Tumour Biol; 2016 Apr; 37(4):5561-8. PubMed ID: 26577850
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
15. [Elevated expression of CLOCK is associated with poor prognosis in hepatocellular carcinoma].
Li B; Yang X; Li J; Yang Y; Yan Z; Zhang H; Mu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):163-168. PubMed ID: 29673458
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
17. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
18. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
[TBL] [Abstract][Full Text] [Related]
19. Replication Protein A 3 Is Associated with Hepatocellular Carcinoma Tumorigenesis and Poor Patient Survival.
Xiao W; Zheng J; Zhou B; Pan L
Dig Dis; 2018; 36(1):26-32. PubMed ID: 28683444
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
